AzTrials
AzTrials

Quality of LifeNCT05729412

Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

An observational study of Quality of Life, run by Kakatiya University at 1 site in India.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient. Need of study: For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve… Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Quality of Life
What is being tested?
Mentioned
How many people
100 participants
Where
1 siteIndia
Study dates
1 Nov 2022to 1 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Any patient prescription which is randomly picked during study period

Who may be able to join

  • Participants who are willing to participate.
  • Participants who are attending in the out-patient department.
  • Participants reported during the study period.
  • Participants who have a prescription which is legible and complete.

Who cannot join

  • Participants who are unwilling to provide the required information.
  • Participants who are not attending the out-patient department.
  • Participants whose prescription is not legible and competent

Trial locations and contacts

1 site in 1 country.

India1 site
  • Max Super Speciality Hospital

    New Delhi, National Capital Territory of Delhi, 110017

Other trials in India

About this study

Official title: A Prescription Audit In The Outpatient Department Of Nabh & Jci Approved Super Speciality Hospital In The Capital Territory Of India

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient.

Need of study:

Read more

For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice

Objectives:

  1. To study the quality of good prescription
  2. In minimization of prescription errors and medication errors
  3. Also to comply with good clinical practice
  4. Enhancement of patient safety
  5. In the maintenance of rational prescribing
  6. To study the quality of care provided by the hospital to the patient

Plan of study:

  • To select the patient based on inclusion and exclusion criteria
  • To collect the information from OP's prescription
  • To identify prescribing errors and medication error
  • To study the management of good prescription

Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design: Observational cohort study Study Duration: 1 month (November 2022)

Read the detailed description

Source of the data: Review of out-patient prescription Sample size: 100 prescription

Possible outcomes:

Minimization of prescribing errors It improves the quality of care Enhancement of patient safety Compliance with good clinical practice In the maintenance of rational prescribing

Conditions
Quality of Life
Being tested
Mentioned
Keywords
Medical Audit, Prescription Audit, Gender difference

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MentionedOther

    Also called Prescription is properly filled

    If prescription is properly filled for specific details than it is compliance

Study groups in NCT05729412
Study groupRoleWhat they receive
CompliancePrescription is filled for specific parameters
Receives: Other: Mentioned
Non-compliancePrescription is not filled for specific parameters
Receives: Other: Mentioned
Not available - NAData not available
Receives: Other: Mentioned

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of prescription

    Data is available sufficient

    Measured: November 01, 2022 to November 30, 2022

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2023
  2. Study start1 Nov 2022
  3. Primary completion1 Jan 2023
  4. Study completion1 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05729412
Sponsor's protocol ID
MAX/IEC/2022/NOV/PA01
Status last verified
Jun 2023
First submitted
31 Jan 2023
Last updated
7 Jun 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: If planned, definitely it would be notified

Questions about this trial

What is this clinical trial studying?

An observational study of Quality of Life, run by Kakatiya University at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of prescription (time frame: November 01, 2022 to November 30, 2022). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in